Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

PROFESS - Forebyggende regime til effektivt at undgå andet slagtilfælde

22. april 2014 opdateret af: Boehringer Ingelheim

PROFESS - Forebyggelsesregime til effektivt at undgå andet slagtilfælde: En dobbeltblind, aktiv og placebokontrolleret undersøgelse af Aggrenox vs. Clopidogrel, med og uden Micardis

Formålet med forsøget er at afgøre, om dipyridamol + aspirin med forlænget frigivelse [Aggrenox, Asasa ntin] er bedre end clopidogrel [Plavix], og om telmisartan [Micardis, Gliosartan, Kinzal, Kinzalm ono, Predxal, Pritor, Samertan, Telmisartan] er overlegen i forhold til placebo, ved tilstedeværelse af antihypertensiv baggrundsterapi, til forebyggelse af et andet slagtilfælde hos patienter, som for nylig har haft et slagtilfælde og derfor er i høj risiko for at få endnu et slagtilfælde.

Studieoversigt

Status

Afsluttet

Betingelser

Intervention / Behandling

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

20332

Fase

  • Fase 4

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

  • Argentina
      • Capital Federal, Argentina
        • 9.159.1331 Boehringer Ingelheim Investigational Site
      • Capital Federal, Argentina
        • 9.159.1333 Boehringer Ingelheim Investigational Site
      • Capital Federal, Argentina
        • 9.159.1334 Boehringer Ingelheim Investigational Site
      • Capital Federal, Argentina
        • 9.159.1335 Boehringer Ingelheim Investigational Site
      • Capital Federal, Argentina
        • 9.159.1336 Boehringer Ingelheim Investigational Site
      • Rosario, Sta. Fe, Argentina
        • 9.159.1332 Boehringer Ingelheim Investigational Site
      • Santa Fe, Argentina
        • 9.159.1342 Boehringer Ingelheim Investigational Site
  • Australien
    • New South Wales
      • Gosford, New South Wales, Australien
        • 9.159.2444 Boehringer Ingelheim Investigational Site
      • New Lambton, New South Wales, Australien
        • 9.159.2449 Boehringer Ingelheim Investigational Site
      • Westmead, New South Wales, Australien
        • 9.159.2448 Boehringer Ingelheim Investigational Site
    • Queensland
      • Herston, Queensland, Australien
        • 9.159.2450 Boehringer Ingelheim Investigational Site
      • Southport, Queensland, Australien
        • 9.159.2452 Boehringer Ingelheim Investigational Site
    • South Australia
      • Bedford Park, South Australia, Australien
        • 9.159.2451 Boehringer Ingelheim Investigational Site
    • Victoria
      • Box Hill, Victoria, Australien
        • 9.159.2443 Boehringer Ingelheim Investigational Site
      • Melbourne, Victoria, Australien
        • 9.159.2447 Boehringer Ingelheim Investigational Site
      • Parkville, Victoria, Australien
        • 9.159.2445 Boehringer Ingelheim Investigational Site
      • West Heidelberg, Victoria, Australien
        • 9.159.2446 Boehringer Ingelheim Investigational Site
  • Belgien
      • Aalst, Belgien
        • 9.159.1553 Boehringer Ingelheim Investigational Site
      • Anderlecht, Belgien
        • 9.159.1543 Boehringer Ingelheim Investigational Site
      • Antwerpen, Belgien
        • 9.159.1552 Boehringer Ingelheim Investigational Site
      • Bonheiden, Belgien
        • 9.159.1546 Boehringer Ingelheim Investigational Site
      • Brugge, Belgien
        • 9.159.1547 Boehringer Ingelheim Investigational Site
      • Bruxelles, Belgien
        • 9.159.1550 Boehringer Ingelheim Investigational Site
      • Hasselt, Belgien
        • 9.159.1549 Boehringer Ingelheim Investigational Site
      • Kortrijk, Belgien
        • 9.159.1555 Boehringer Ingelheim Investigational Site
      • La Louvière, Belgien
        • 9.159.1554 Boehringer Ingelheim Investigational Site
      • Leuven, Belgien
        • 9.159.1544 Boehringer Ingelheim Investigational Site
      • Montegnée, Belgien
        • 9.159.1548 Boehringer Ingelheim Investigational Site
      • Ottignies, Belgien
        • 9.159.1556 Boehringer Ingelheim Investigational Site
      • Wilrijk, Belgien
        • 9.159.1545 Boehringer Ingelheim Investigational Site
      • Yvoir, Belgien
        • 9.159.1551 Boehringer Ingelheim Investigational Site
  • Brasilien
      • Salvador, Brasilien
        • 9.159.2869 Complexo Hospitalar Universitario Prof Edgard Santos
      • São Paulo, Brasilien
        • 9.159.2853 Boehringer Ingelheim Investigational Site
  • Canada
    • Alberta
      • Calgary, Alberta, Canada
        • 9.159.1397 Foothills Medical Centre
      • Edmonton, Alberta, Canada
        • 9.159.1382 Boehringer Ingelheim Investigational Site
      • Lethbridge, Alberta, Canada
        • 9.159.1390 Boehringer Ingelheim Investigational Site
    • British Columbia
      • Kamloops, British Columbia, Canada
        • 9.159.1370 Boehringer Ingelheim Investigational Site
      • New Westminster, British Columbia, Canada
        • 9.159.1368 Boehringer Ingelheim Investigational Site
      • Penticton, British Columbia, Canada
        • 9.159.1376 Boehringer Ingelheim Investigational Site
      • Vancouver, British Columbia, Canada
        • 9.159.1387 Boehringer Ingelheim Investigational Site
      • Victoria, British Columbia, Canada
        • 9.159.1377 Boehringer Ingelheim Investigational Site
    • Manitoba
      • Winnipeg, Manitoba, Canada
        • 9.159.1355 Boehringer Ingelheim Investigational Site
      • Winnipeg, Manitoba, Canada
        • 9.159.1394 Boehringer Ingelheim Investigational Site
    • New Brunswick
      • Saint John, New Brunswick, Canada
        • 9.159.1356 Boehringer Ingelheim Investigational Site
    • Newfoundland and Labrador
      • Corner Brook, Newfoundland and Labrador, Canada
        • 9.159.1392 Boehringer Ingelheim Investigational Site
      • St. John's, Newfoundland and Labrador, Canada
        • 9.159.1385 Boehringer Ingelheim Investigational Site
    • Nova Scotia
      • Sydney, Nova Scotia, Canada
        • 9.159.1373 Boehringer Ingelheim Investigational Site
    • Ontario
      • Barrie, Ontario, Canada
        • 9.159.1393 Boehringer Ingelheim Investigational Site
      • Hamilton, Ontario, Canada
        • 9.159.1395 Boehringer Ingelheim Investigational Site
      • Kingston, Ontario, Canada
        • 9.159.1360 Boehringer Ingelheim Investigational Site
      • London, Ontario, Canada
        • 9.159.1367 Boehringer Ingelheim Investigational Site
      • London, Ontario, Canada
        • 9.159.1384 Boehringer Ingelheim Investigational Site
      • Mississauga, Ontario, Canada
        • 9.159.1380 Boehringer Ingelheim Investigational Site
      • Ottawa, Ontario, Canada
        • 9.159.1378 Boehringer Ingelheim Investigational Site
      • Ottawa, Ontario, Canada
        • 9.159.1381 Ottawa Hospital General Campus
      • Richmond Hill, Ontario, Canada
        • 9.159.1366 Boehringer Ingelheim Investigational Site
      • Scarborough, Ontario, Canada
        • 9.159.1365 Boehringer Ingelheim Investigational Site
      • Scarborough, Ontario, Canada
        • 9.159.1375 Boehringer Ingelheim Investigational Site
      • Tecumseh, Ontario, Canada
        • 9.159.1391 Boehringer Ingelheim Investigational Site
      • Thunder Bay, Ontario, Canada
        • 9.159.1369 Boehringer Ingelheim Investigational Site
      • Toronto, Ontario, Canada
        • 9.159.1357 Boehringer Ingelheim Investigational Site
      • Toronto, Ontario, Canada
        • 9.159.1379 Boehringer Ingelheim Investigational Site
      • Toronto, Ontario, Canada
        • 9.159.1383 Boehringer Ingelheim Investigational Site
      • Windsor, Ontario, Canada
        • 9.159.1363 Boehringer Ingelheim Investigational Site
    • Quebec
      • Greenfield Park, Quebec, Canada
        • 9.159.1359 Boehringer Ingelheim Investigational Site
      • Montreal, Quebec, Canada
        • 9.159.1361 Boehringer Ingelheim Investigational Site
      • Montreal, Quebec, Canada
        • 9.159.1362 Boehringer Ingelheim Investigational Site
      • Montreal, Quebec, Canada
        • 9.159.1371 Boehringer Ingelheim Investigational Site
      • Montreal, Quebec, Canada
        • 9.159.1374 Boehringer Ingelheim Investigational Site
      • Montreal, Quebec, Canada
        • 9.159.1388 Boehringer Ingelheim Investigational Site
      • Quebec City, Quebec, Canada
        • 9.159.1372 Boehringer Ingelheim Investigational Site
      • Saguenay, Quebec, Canada
        • 9.159.1358 Boehringer Ingelheim Investigational Site
      • St. Jerome, Quebec, Canada
        • 9.159.1364 Boehringer Ingelheim Investigational Site
    • Saskatchewan
      • Regina, Saskatchewan, Canada
        • 9.159.1389 Boehringer Ingelheim Investigational Site
      • Saskatoon, Saskatchewan, Canada
        • 9.159.1396 Boehringer Ingelheim Investigational Site
  • Danmark
      • Aarhuc C, Danmark
        • 9.159.1636 Boehringer Ingelheim Investigational Site
      • Aarhus C, Danmark
        • 9.159.1635 Boehringer Ingelheim Investigational Site
      • Esbjerg, Danmark
        • 9.159.1639 Boehringer Ingelheim Investigational Site
      • Frederiksberg, Danmark
        • 9.159.1634 Boehringer Ingelheim Investigational Site
      • Glostrup, Danmark
        • 9.159.1637 Boehringer Ingelheim Investigational Site
      • Hellerup, Danmark
        • 9.159.1640 Boehringer Ingelheim Investigational Site
      • Hvidovre, Danmark
        • 9.159.1638 Boehringer Ingelheim Investigational Site
      • København NV, Danmark
        • 9.159.1633 Boehringer Ingelheim Investigational Site
      • København Ø, Danmark
        • 9.159.1631 Boehringer Ingelheim Investigational Site
      • Odense, Danmark
        • 9.159.1632 Boehringer Ingelheim Investigational Site
  • Den Russiske Føderation
      • Ekaterinburg, Den Russiske Føderation
        • 9.159.2114 Boehringer Ingelheim Investigational Site
      • Kazan, Den Russiske Føderation
        • 9.159.2102 Boehringer Ingelheim Investigational Site
      • Kemerovo, Den Russiske Føderation
        • 9.159.2117 Boehringer Ingelheim Investigational Site
      • Kirov, Den Russiske Føderation
        • 9.159.2107 Boehringer Ingelheim Investigational Site
      • Krasnoyarsk, Den Russiske Føderation
        • 9.159.2116 Boehringer Ingelheim Investigational Site
      • Moscow, Den Russiske Føderation
        • 9.159.2079 Boehringer Ingelheim Investigational Site
      • Moscow, Den Russiske Føderation
        • 9.159.2080 Boehringer Ingelheim Investigational Site
      • Moscow, Den Russiske Føderation
        • 9.159.2081 Boehringer Ingelheim Investigational Site
      • Moscow, Den Russiske Føderation
        • 9.159.2082 Boehringer Ingelheim Investigational Site
      • Moscow, Den Russiske Føderation
        • 9.159.2083 Boehringer Ingelheim Investigational Site
      • Moscow, Den Russiske Føderation
        • 9.159.2084 Boehringer Ingelheim Investigational Site
      • Moscow, Den Russiske Føderation
        • 9.159.2085 Boehringer Ingelheim Investigational Site
      • Moscow, Den Russiske Føderation
        • 9.159.2087 Boehringer Ingelheim Investigational Site
      • Moscow, Den Russiske Føderation
        • 9.159.2088 Boehringer Ingelheim Investigational Site
      • Moscow, Den Russiske Føderation
        • 9.159.2089 Boehringer Ingelheim Investigational Site
      • Moscow, Den Russiske Føderation
        • 9.159.2090 Boehringer Ingelheim Investigational Site
      • Moscow, Den Russiske Føderation
        • 9.159.2091 Boehringer Ingelheim Investigational Site
      • Moscow, Den Russiske Føderation
        • 9.159.2092 Boehringer Ingelheim Investigational Site
      • Moscow, Den Russiske Føderation
        • 9.159.2093 Boehringer Ingelheim Investigational Site
      • Moscow, Den Russiske Føderation
        • 9.159.2095 Boehringer Ingelheim Investigational Site
      • Moscow, Den Russiske Føderation
        • 9.159.2098 Boehringer Ingelheim Investigational Site
      • Moscow, Den Russiske Føderation
        • 9.159.2101 Boehringer Ingelheim Investigational Site
      • Nizhnyi Novgorod, Den Russiske Føderation
        • 9.159.2105 Boehringer Ingelheim Investigational Site
      • Novosibirsk, Den Russiske Føderation
        • 9.159.2115 Boehringer Ingelheim Investigational Site
      • Omsk, Den Russiske Føderation
        • 9.159.2119 Boehringer Ingelheim Investigational Site
      • Orel, Den Russiske Føderation
        • 9.159.2111 Boehringer Ingelheim Investigational Site
      • Rostov-na-Donu, Den Russiske Føderation
        • 9.159.2106 Boehringer Ingelheim Investigational Site
      • Samara, Den Russiske Føderation
        • 9.159.2108 Boehringer Ingelheim Investigational Site
      • Saratov, Den Russiske Føderation
        • 9.159.2109 Boehringer Ingelheim Investigational Site
      • Saratov, Den Russiske Føderation
        • 9.159.2110 Boehringer Ingelheim Investigational Site
      • Seversk, Den Russiske Føderation
        • 9.159.2118 Boehringer Ingelheim Investigational Site
      • Smolensk, Den Russiske Føderation
        • 9.159.2086 Boehringer Ingelheim Investigational Site
      • St. Petersburg, Den Russiske Føderation
        • 9.159.2094 Boehringer Ingelheim Investigational Site
      • St. Petersburg, Den Russiske Føderation
        • 9.159.2097 Boehringer Ingelheim Investigational Site
      • St. Petersburg, Den Russiske Føderation
        • 9.159.2099 Boehringer Ingelheim Investigational Site
      • St. Petersburg, Den Russiske Føderation
        • 9.159.2100 Boehringer Ingelheim Investigational Site
      • Ufa, Den Russiske Føderation
        • 9.159.2120 Boehringer Ingelheim Investigational Site
      • Volgograd, Den Russiske Føderation
        • 9.159.2112 Boehringer Ingelheim Investigational Site
      • Volgograd, Den Russiske Føderation
        • 9.159.2113 Boehringer Ingelheim Investigational Site
      • Voronezh, Den Russiske Føderation
        • 9.159.2104 Boehringer Ingelheim Investigational Site
      • Yaroslavl, Den Russiske Føderation
        • 9.159.2103 Boehringer Ingelheim Investigational Site
  • Det Forenede Kongerige
      • Belfast, Det Forenede Kongerige
        • 9.159.2304 Boehringer Ingelheim Investigational Site
      • Birmingham, Det Forenede Kongerige
        • 9.159.2297 Boehringer Ingelheim Investigational Site
      • Bournemouth, Det Forenede Kongerige
        • 9.159.2299 Boehringer Ingelheim Investigational Site
      • Bristol, Det Forenede Kongerige
        • 9.159.2301 Boehringer Ingelheim Investigational Site
      • Dundee, Det Forenede Kongerige
        • 9.159.2298 Boehringer Ingelheim Investigational Site
      • Exeter, Det Forenede Kongerige
        • 9.159.2307 Boehringer Ingelheim Investigational Site
      • Glasgow, Det Forenede Kongerige
        • 9.159.2296 Boehringer Ingelheim Investigational Site
      • Glasgow, Det Forenede Kongerige
        • 9.159.2300 Boehringer Ingelheim Investigational Site
      • Harrow, Det Forenede Kongerige
        • 9.159.2287 Boehringer Ingelheim Investigational Site
      • Henshingham, Whitehaven, Det Forenede Kongerige
        • 9.159.2303 Boehringer Ingelheim Investigational Site
      • Leicester, Det Forenede Kongerige
        • 9.159.2308 Boehringer Ingelheim Investigational Site
      • Liverpool, Det Forenede Kongerige
        • 9.159.2295 Boehringer Ingelheim Investigational Site
      • London, Det Forenede Kongerige
        • 9.159.2286 Boehringer Ingelheim Investigational Site
      • London, Det Forenede Kongerige
        • 9.159.2293 Boehringer Ingelheim Investigational Site
      • London, Det Forenede Kongerige
        • 9.159.2294 Boehringer Ingelheim Investigational Site
      • Mansfield, Det Forenede Kongerige
        • 9.159.2305 Boehringer Ingelheim Investigational Site
      • Newcastle Upon Tyne, Det Forenede Kongerige
        • 9.159.2290 Boehringer Ingelheim Investigational Site
      • North Shields, Det Forenede Kongerige
        • 9.159.2288 Boehringer Ingelheim Investigational Site
      • Northampton, Det Forenede Kongerige
        • 9.159.2285 Boehringer Ingelheim Investigational Site
      • Nottingham, Det Forenede Kongerige
        • 9.159.2284 Boehringer Ingelheim Investigational Site
      • Poole, Det Forenede Kongerige
        • 9.159.2283 Boehringer Ingelheim Investigational Site
      • Rotherham, Det Forenede Kongerige
        • 9.159.2302 Boehringer Ingelheim Investigational Site
      • Sheffield, Det Forenede Kongerige
        • 9.159.2292 Boehringer Ingelheim Investigational Site
      • Southampton, Det Forenede Kongerige
        • 9.159.2289 Boehringer Ingelheim Investigational Site
      • Stoke on Trent, Det Forenede Kongerige
        • 9.159.2306 Boehringer Ingelheim Investigational Site
      • Sunderland, Det Forenede Kongerige
        • 9.159.2291 Boehringer Ingelheim Investigational Site
  • El Salvador
      • Oviedo, El Salvador
        • 9.159.2181 Boehringer Ingelheim Investigational Site
  • Finland
      • Helsinki, Finland
        • 9.159.1655 Boehringer Ingelheim Investigational Site
      • Kuopio, Finland
        • 9.159.1658 Boehringer Ingelheim Investigational Site
      • Lappeenranta, Finland
        • 9.159.1659 Boehringer Ingelheim Investigational Site
      • Oulu, Finland
        • 9.159.1656 Boehringer Ingelheim Investigational Site
      • Seinäjoki, Finland
        • 9.159.1657 Boehringer Ingelheim Investigational Site
  • Forenede Stater
    • Alabama
      • Birmingham, Alabama, Forenede Stater
        • 9.159.1101 Boehringer Ingelheim Investigational Site
      • Huntsville, Alabama, Forenede Stater
        • 9.159.1173 Boehringer Ingelheim Investigational Site
      • Mobile, Alabama, Forenede Stater
        • 9.159.1058 Boehringer Ingelheim Investigational Site
      • Montgomery, Alabama, Forenede Stater
        • 9.159.1087 Boehringer Ingelheim Investigational Site
      • Northport, Alabama, Forenede Stater
        • 9.159.1081 Boehringer Ingelheim Investigational Site
    • Arizona
      • Phoenix, Arizona, Forenede Stater
        • 9.159.1022 Boehringer Ingelheim Investigational Site
      • Phoenix, Arizona, Forenede Stater
        • 9.159.1133 Boehringer Ingelheim Investigational Site
      • Phoenix, Arizona, Forenede Stater
        • 9.159.1149 Boehringer Ingelheim Investigational Site
      • Tucson, Arizona, Forenede Stater
        • 9.159.1137 Boehringer Ingelheim Investigational Site
    • Arkansas
      • Fayetteville, Arkansas, Forenede Stater
        • 9.159.1184 Boehringer Ingelheim Investigational Site
      • Fort Smith, Arkansas, Forenede Stater
        • 9.159.1005 Boehringer Ingelheim Investigational Site
      • Jonesboro, Arkansas, Forenede Stater
        • 9.159.1136 Boehringer Ingelheim Investigational Site
      • Little Rock, Arkansas, Forenede Stater
        • 9.159.1062 Boehringer Ingelheim Investigational Site
    • California
      • Berkeley, California, Forenede Stater
        • 9.159.1040 Boehringer Ingelheim Investigational Site
      • Carmichael, California, Forenede Stater
        • 9.159.1180 Boehringer Ingelheim Investigational Site
      • Irvine, California, Forenede Stater
        • 9.159.1114 Boehringer Ingelheim Investigational Site
      • Laguna Hills, California, Forenede Stater
        • 9.159.1202 Boehringer Ingelheim Investigational Site
      • Los Angeles, California, Forenede Stater
        • 9.159.1036 Boehringer Ingelheim Investigational Site
      • Los Angeles, California, Forenede Stater
        • 9.159.1052 Boehringer Ingelheim Investigational Site
      • Los Angeles, California, Forenede Stater
        • 9.159.1100 Boehringer Ingelheim Investigational Site
      • Los Angeles, California, Forenede Stater
        • 9.159.1111 Boehringer Ingelheim Investigational Site
      • Los Angeles, California, Forenede Stater
        • 9.159.1165 Boehringer Ingelheim Investigational Site
      • Oceanside, California, Forenede Stater
        • 9.159.1134 Boehringer Ingelheim Investigational Site
      • Palo Alto, California, Forenede Stater
        • 9.159.1002 Boehringer Ingelheim Investigational Site
      • Redding, California, Forenede Stater
        • 9.159.1108 Boehringer Ingelheim Investigational Site
      • Sacramento, California, Forenede Stater
        • 9.159.1013 Boehringer Ingelheim Investigational Site
      • Sacramento, California, Forenede Stater
        • 9.159.1198 Boehringer Ingelheim Investigational Site
      • San Diego, California, Forenede Stater
        • 9.159.1029 Boehringer Ingelheim Investigational Site
      • San Francisco, California, Forenede Stater
        • 9.159.1185 Boehringer Ingelheim Investigational Site
      • San Jose, California, Forenede Stater
        • 9.159.1218 Boehringer Ingelheim Investigational Site
      • Santa Rosa, California, Forenede Stater
        • 9.159.1179 Boehringer Ingelheim Investigational Site
      • Sylmar, California, Forenede Stater
        • 9.159.1162 Boehringer Ingelheim Investigational Site
      • Torrance, California, Forenede Stater
        • 9.159.1183 Boehringer Ingelheim Investigational Site
      • Walnut Creek, California, Forenede Stater
        • 9.159.1205 Boehringer Ingelheim Investigational Site
    • Colorado
      • Denver, Colorado, Forenede Stater
        • 9.159.1118 Boehringer Ingelheim Investigational Site
      • Englewood, Colorado, Forenede Stater
        • 9.159.1045 Boehringer Ingelheim Investigational Site
    • Connecticut
      • Danbury, Connecticut, Forenede Stater
        • 9.159.1038 Boehringer Ingelheim Investigational Site
      • Fairfield, Connecticut, Forenede Stater
        • 9.159.1196 Boehringer Ingelheim Investigational Site
      • Hartford, Connecticut, Forenede Stater
        • 9.159.1018 Boehringer Ingelheim Investigational Site
    • Delaware
      • Newark, Delaware, Forenede Stater
        • 9.159.1080 Boehringer Ingelheim Investigational Site
    • District of Columbia
      • Washington, District of Columbia, Forenede Stater
        • 9.159.1120 Boehringer Ingelheim Investigational Site
      • Washington, District of Columbia, Forenede Stater
        • 9.159.1216 Boehringer Ingelheim Investigational Site
    • Florida
      • Bay Pines, Florida, Forenede Stater
        • 9.159.1057 Boehringer Ingelheim Investigational Site
      • Boca Raton, Florida, Forenede Stater
        • 9.159.1217 Boehringer Ingelheim Investigational Site
      • Bradenton, Florida, Forenede Stater
        • 9.159.1096 Boehringer Ingelheim Investigational Site
      • Clearwater, Florida, Forenede Stater
        • 9.159.1144 Boehringer Ingelheim Investigational Site
      • Ft. Lauderdale, Florida, Forenede Stater
        • 9.159.1007 Boehringer Ingelheim Investigational Site
      • Jacksonville, Florida, Forenede Stater
        • 9.159.1190 Boehringer Ingelheim Investigational Site
      • Ocala, Florida, Forenede Stater
        • 9.159.1150 Boehringer Ingelheim Investigational Site
      • Panama City, Florida, Forenede Stater
        • 9.159.1153 Boehringer Ingelheim Investigational Site
      • Plantation, Florida, Forenede Stater
        • 9.159.1041 Boehringer Ingelheim Investigational Site
      • Port Charlotte, Florida, Forenede Stater
        • 9.159.1072 Boehringer Ingelheim Investigational Site
      • Sarasota, Florida, Forenede Stater
        • 9.159.1063 Boehringer Ingelheim Investigational Site
      • Tampa, Florida, Forenede Stater
        • 9.159.1208 Boehringer Ingelheim Investigational Site
      • Vero Beach, Florida, Forenede Stater
        • 9.159.1049 Boehringer Ingelheim Investigational Site
      • West Palm Beach, Florida, Forenede Stater
        • 9.159.1176 Boehringer Ingelheim Investigational Site
    • Georgia
      • Atlanta, Georgia, Forenede Stater
        • 9.159.1071 Boehringer Ingelheim Investigational Site
      • Augusta, Georgia, Forenede Stater
        • 9.159.1079 Boehringer Ingelheim Investigational Site
      • Columbus, Georgia, Forenede Stater
        • 9.159.1181 Boehringer Ingelheim Investigational Site
      • Decatur, Georgia, Forenede Stater
        • 9.159.1138 Boehringer Ingelheim Investigational Site
      • Rome, Georgia, Forenede Stater
        • 9.159.1070 Boehringer Ingelheim Investigational Site
      • Savannah, Georgia, Forenede Stater
        • 9.159.1107 Boehringer Ingelheim Investigational Site
    • Idaho
      • Boise, Idaho, Forenede Stater
        • 9.159.1189 Boehringer Ingelheim Investigational Site
    • Illinois
      • Chicago, Illinois, Forenede Stater
        • 9.159.1026 University of Illinois
      • Chicago, Illinois, Forenede Stater
        • 9.159.1033 Boehringer Ingelheim Investigational Site
      • Chicago, Illinois, Forenede Stater
        • 9.159.1060 Boehringer Ingelheim Investigational Site
      • Maywood, Illinois, Forenede Stater
        • 9.159.1044 Boehringer Ingelheim Investigational Site
      • Palos Heights, Illinois, Forenede Stater
        • 9.159.1054 Boehringer Ingelheim Investigational Site
      • Park Ridge, Illinois, Forenede Stater
        • 9.159.1068 Boehringer Ingelheim Investigational Site
      • Peoria, Illinois, Forenede Stater
        • 9.159.1178 Boehringer Ingelheim Investigational Site
    • Indiana
      • Elkhart, Indiana, Forenede Stater
        • 9.159.1156 Boehringer Ingelheim Investigational Site
      • South Bend, Indiana, Forenede Stater
        • 9.159.1092 Boehringer Ingelheim Investigational Site
    • Iowa
      • Cedar Rapids, Iowa, Forenede Stater
        • 9.159.1027 Boehringer Ingelheim Investigational Site
      • Des Moines, Iowa, Forenede Stater
        • 9.159.1119 Boehringer Ingelheim Investigational Site
      • Des Moines, Iowa, Forenede Stater
        • 9.159.1187 Boehringer Ingelheim Investigational Site
      • Iowa City, Iowa, Forenede Stater
        • 9.159.1059 Boehringer Ingelheim Investigational Site
      • Waterloo, Iowa, Forenede Stater
        • 9.159.1135 Boehringer Ingelheim Investigational Site
    • Kansas
      • Kansas City, Kansas, Forenede Stater
        • 9.159.1090 Boehringer Ingelheim Investigational Site
    • Kentucky
      • Lexington, Kentucky, Forenede Stater
        • 9.159.1129 Central Baptis Hospital
      • Lexington, Kentucky, Forenede Stater
        • 9.159.1131 Boehringer Ingelheim Investigational Site
      • Lexington, Kentucky, Forenede Stater
        • 9.159.1206 Boehringer Ingelheim Investigational Site
      • Lexington, Kentucky, Forenede Stater
        • 9.159.1212 Boehringer Ingelheim Investigational Site
      • Louisville, Kentucky, Forenede Stater
        • 9.159.1091 Boehringer Ingelheim Investigational Site
      • Louisville, Kentucky, Forenede Stater
        • 9.159.1147 Boehringer Ingelheim Investigational Site
    • Louisiana
      • Baton Rouge, Louisiana, Forenede Stater
        • 9.159.1106 Boehringer Ingelheim Investigational Site
      • Marrero, Louisiana, Forenede Stater
        • 9.159.1194 Boehringer Ingelheim Investigational Site
      • New Orleans, Louisiana, Forenede Stater
        • 9.159.1083 Boehringer Ingelheim Investigational Site
      • Shreveport, Louisiana, Forenede Stater
        • 9.159.1195 Boehringer Ingelheim Investigational Site
    • Maryland
      • Baltimore, Maryland, Forenede Stater
        • 9.159.1024 Boehringer Ingelheim Investigational Site
      • Baltimore, Maryland, Forenede Stater
        • 9.159.1055 Boehringer Ingelheim Investigational Site
      • Baltimore, Maryland, Forenede Stater
        • 9.159.1139 Boehringer Ingelheim Investigational Site
    • Massachusetts
      • Boston, Massachusetts, Forenede Stater
        • 9.159.1031 Boehringer Ingelheim Investigational Site
      • Boston, Massachusetts, Forenede Stater
        • 9.159.1066 Boehringer Ingelheim Investigational Site
      • Boston, Massachusetts, Forenede Stater
        • 9.159.1104 Boehringer Ingelheim Investigational Site
      • Boston, Massachusetts, Forenede Stater
        • 9.159.1166 Boehringer Ingelheim Investigational Site
      • South Weymouth, Massachusetts, Forenede Stater
        • 9.159.1192 Boehringer Ingelheim Investigational Site
      • Worchester, Massachusetts, Forenede Stater
        • 9.159.1039 Boehringer Ingelheim Investigational Site
    • Michigan
      • Detroit, Michigan, Forenede Stater
        • 9.159.1019 Boehringer Ingelheim Investigational Site
      • Detroit, Michigan, Forenede Stater
        • 9.159.1048 Boehringer Ingelheim Investigational Site
      • Detroit, Michigan, Forenede Stater
        • 9.159.1089 Boehringer Ingelheim Investigational Site
      • East Lansing, Michigan, Forenede Stater
        • 9.159.1078 Boehringer Ingelheim Investigational Site
      • Grand Rapids, Michigan, Forenede Stater
        • 9.159.1143 Boehringer Ingelheim Investigational Site
      • Kalamazoo, Michigan, Forenede Stater
        • 9.159.1102 Boehringer Ingelheim Investigational Site
      • Saginaw, Michigan, Forenede Stater
        • 9.159.1011 Boehringer Ingelheim Investigational Site
      • Southfield, Michigan, Forenede Stater
        • 9.159.1132 Boehringer Ingelheim Investigational Site
    • Minnesota
      • Duluth, Minnesota, Forenede Stater
        • 9.159.1088 Boehringer Ingelheim Investigational Site
      • Duluth, Minnesota, Forenede Stater
        • 9.159.1158 Boehringer Ingelheim Investigational Site
      • Golden Valley, Minnesota, Forenede Stater
        • 9.159.1084 Boehringer Ingelheim Investigational Site
      • Minneapolis, Minnesota, Forenede Stater
        • 9.159.1097 Boehringer Ingelheim Investigational Site
      • Minneapolis, Minnesota, Forenede Stater
        • 9.159.1113 Boehringer Ingelheim Investigational Site
    • Missouri
      • Kansas City, Missouri, Forenede Stater
        • 9.159.1128 St. Luke's Hospital MABSI Research
      • Lees Summit, Missouri, Forenede Stater
        • 9.159.1172 Boehringer Ingelheim Investigational Site
      • Saint Louis, Missouri, Forenede Stater
        • 9.159.1174 Boehringer Ingelheim Investigational Site
      • Springfield, Missouri, Forenede Stater
        • 9.159.1009 Boehringer Ingelheim Investigational Site
      • St. Louis, Missouri, Forenede Stater
        • 9.159.1182 Boehringer Ingelheim Investigational Site
      • St. Louis, Missouri, Forenede Stater
        • 9.159.1191 Boehringer Ingelheim Investigational Site
    • Montana
      • Great Falls, Montana, Forenede Stater
        • 9.159.1146 Boehringer Ingelheim Investigational Site
    • Nebraska
      • Omaha, Nebraska, Forenede Stater
        • 9.159.1201 Boehringer Ingelheim Investigational Site
    • Nevada
      • Las Vegas, Nevada, Forenede Stater
        • 9.159.1127 Boehringer Ingelheim Investigational Site
      • Reno, Nevada, Forenede Stater
        • 9.159.1188 Boehringer Ingelheim Investigational Site
    • New Jersey
      • Camden, New Jersey, Forenede Stater
        • 9.159.1204 Boehringer Ingelheim Investigational Site
      • Edison, New Jersey, Forenede Stater
        • 9.159.1203 Boehringer Ingelheim Investigational Site
      • Lumberton, New Jersey, Forenede Stater
        • 9.159.1042 Neurology Consultants of Burlington County
      • New Brunswick, New Jersey, Forenede Stater
        • 9.159.1209 Boehringer Ingelheim Investigational Site
      • Newark, New Jersey, Forenede Stater
        • 9.159.1125 Boehringer Ingelheim Investigational Site
      • Ridgewood, New Jersey, Forenede Stater
        • 9.159.1095 Boehringer Ingelheim Investigational Site
    • New Mexico
      • Albuquerque, New Mexico, Forenede Stater
        • 9.159.1170 Boehringer Ingelheim Investigational Site
    • New York
      • Albany, New York, Forenede Stater
        • 9.159.1086 Boehringer Ingelheim Investigational Site
      • Bronx, New York, Forenede Stater
        • 9.159.1121 Boehringer Ingelheim Investigational Site
      • Bronx, New York, Forenede Stater
        • 9.159.1130 Boehringer Ingelheim Investigational Site
      • Brooklyn, New York, Forenede Stater
        • 9.159.1017 Boehringer Ingelheim Investigational Site
      • Brooklyn, New York, Forenede Stater
        • 9.159.1064 Boehringer Ingelheim Investigational Site
      • Brooklyn, New York, Forenede Stater
        • 9.159.1186 Boehringer Ingelheim Investigational Site
      • Buffalo, New York, Forenede Stater
        • 9.159.1151 Boehringer Ingelheim Investigational Site
      • Manasset, New York, Forenede Stater
        • 9.159.1076 North Shore University Hospital
      • Mineola, New York, Forenede Stater
        • 9.159.1037 Boehringer Ingelheim Investigational Site
      • New Hyde Park, New York, Forenede Stater
        • 9.159.1220 Boehringer Ingelheim Investigational Site
      • New York, New York, Forenede Stater
        • 9.159.1001 Boehringer Ingelheim Investigational Site
      • New York, New York, Forenede Stater
        • 9.159.1116 Boehringer Ingelheim Investigational Site
      • New York, New York, Forenede Stater
        • 9.159.1142 Saint Luke's-Roosevelt Hospital
      • Schenectady, New York, Forenede Stater
        • 9.159.1126 Boehringer Ingelheim Investigational Site
      • Stony Brook, New York, Forenede Stater
        • 9.159.1163 Boehringer Ingelheim Investigational Site
      • Tonawanda, New York, Forenede Stater
        • 9.159.1169 Boehringer Ingelheim Investigational Site
      • White Plains, New York, Forenede Stater
        • 9.159.1065 Boehringer Ingelheim Investigational Site
    • North Carolina
      • Asheville, North Carolina, Forenede Stater
        • 9.159.1099 Boehringer Ingelheim Investigational Site
      • Chapel Hill, North Carolina, Forenede Stater
        • 9.159.1046 Boehringer Ingelheim Investigational Site
      • Durham, North Carolina, Forenede Stater
        • 9.159.1094 Boehringer Ingelheim Investigational Site
      • High Point, North Carolina, Forenede Stater
        • 9.159.1012 Boehringer Ingelheim Investigational Site
      • Wilmington, North Carolina, Forenede Stater
        • 9.159.1115
      • Winston-Salem, North Carolina, Forenede Stater
        • 9.159.1051 Boehringer Ingelheim Investigational Site
      • Winston-Salem, North Carolina, Forenede Stater
        • 9.159.1110 Boehringer Ingelheim Investigational Site
    • North Dakota
      • Bismarck, North Dakota, Forenede Stater
        • 9.159.1215 Boehringer Ingelheim Investigational Site
      • Fargo, North Dakota, Forenede Stater
        • 9.159.1152 Boehringer Ingelheim Investigational Site
    • Ohio
      • Akron, Ohio, Forenede Stater
        • 9.159.1159 Boehringer Ingelheim Investigational Site
      • Canton, Ohio, Forenede Stater
        • 9.159.1085 Boehringer Ingelheim Investigational Site
      • Cincinnati, Ohio, Forenede Stater
        • 9.159.1032 Boehringer Ingelheim Investigational Site
      • Cleveland, Ohio, Forenede Stater
        • 9.159.1025 Boehringer Ingelheim Investigational Site
      • Cleveland, Ohio, Forenede Stater
        • 9.159.1177 Boehringer Ingelheim Investigational Site
      • Columbus, Ohio, Forenede Stater
        • 9.159.1008 Boehringer Ingelheim Investigational Site
      • Columbus, Ohio, Forenede Stater
        • 9.159.1141 Boehringer Ingelheim Investigational Site
      • Toledo, Ohio, Forenede Stater
        • 9.159.1053 Boehringer Ingelheim Investigational Site
      • Youngstown, Ohio, Forenede Stater
        • 9.159.1122 Boehringer Ingelheim Investigational Site
    • Oklahoma
      • Oklahoma City, Oklahoma, Forenede Stater
        • 9.159.1199 Boehringer Ingelheim Investigational Site
    • Oregon
      • Portland, Oregon, Forenede Stater
        • 9.159.1010 Boehringer Ingelheim Investigational Site
    • Pennsylvania
      • Abington, Pennsylvania, Forenede Stater
        • 9.159.1171 Boehringer Ingelheim Investigational Site
      • Allentown, Pennsylvania, Forenede Stater
        • 9.159.1210 Boehringer Ingelheim Investigational Site
      • Allentown, Pennsylvania, Forenede Stater
        • 9.159.1214 Boehringer Ingelheim Investigational Site
      • Erie, Pennsylvania, Forenede Stater
        • 9.159.1200 Boehringer Ingelheim Investigational Site
      • Greensburg, Pennsylvania, Forenede Stater
        • 9.159.1043 Boehringer Ingelheim Investigational Site
      • Hershey, Pennsylvania, Forenede Stater
        • 9.159.1164 Boehringer Ingelheim Investigational Site
      • Lancaster, Pennsylvania, Forenede Stater
        • 9.159.1175 Boehringer Ingelheim Investigational Site
      • Philadelphia, Pennsylvania, Forenede Stater
        • 9.159.1016 Boehringer Ingelheim Investigational Site
      • Philadelphia, Pennsylvania, Forenede Stater
        • 9.159.1056 Boehringer Ingelheim Investigational Site
      • Philadelphia, Pennsylvania, Forenede Stater
        • 9.159.1074 Boehringer Ingelheim Investigational Site
      • Pittsburgh, Pennsylvania, Forenede Stater
        • 9.159.1112 Boehringer Ingelheim Investigational Site
      • Upland, Pennsylvania, Forenede Stater
        • 9.159.1148 Boehringer Ingelheim Investigational Site
    • Rhode Island
      • Providence, Rhode Island, Forenede Stater
        • 9.159.1123 Boehringer Ingelheim Investigational Site
    • South Carolina
      • Columbia, South Carolina, Forenede Stater
        • 9.159.1140 Boehringer Ingelheim Investigational Site
      • Greenville, South Carolina, Forenede Stater
        • 9.159.1207 Boehringer Ingelheim Investigational Site
      • Spartanberg, South Carolina, Forenede Stater
        • 9.159.1004 Boehringer Ingelheim Investigational Site
    • Tennessee
      • Bristol, Tennessee, Forenede Stater
        • 9.159.1006 Boehringer Ingelheim Investigational Site
      • Knoxville, Tennessee, Forenede Stater
        • 9.159.1154 Boehringer Ingelheim Investigational Site
      • Memphis, Tennessee, Forenede Stater
        • 9.159.1213 Boehringer Ingelheim Investigational Site
      • Nashville, Tennessee, Forenede Stater
        • 9.159.1075 Boehringer Ingelheim Investigational Site
    • Texas
      • Brownwood, Texas, Forenede Stater
        • 9.159.1219 Boehringer Ingelheim Investigational Site
      • Dallas, Texas, Forenede Stater
        • 9.159.1155 Boehringer Ingelheim Investigational Site
      • Dallas, Texas, Forenede Stater
        • 9.159.1197 Boehringer Ingelheim Investigational Site
      • Houston, Texas, Forenede Stater
        • 9.159.1020 Boehringer Ingelheim Investigational Site
      • Houston, Texas, Forenede Stater
        • 9.159.1023 Boehringer Ingelheim Investigational Site
      • Houston, Texas, Forenede Stater
        • 9.159.1082 Boehringer Ingelheim Investigational Site
      • Houston, Texas, Forenede Stater
        • 9.159.1160 Boehringer Ingelheim Investigational Site
      • San Antonio, Texas, Forenede Stater
        • 9.159.1047 Boehringer Ingelheim Investigational Site
      • Tyler, Texas, Forenede Stater
        • 9.159.1069 Boehringer Ingelheim Investigational Site
    • Utah
      • Bountiful, Utah, Forenede Stater
        • 9.159.1003 Boehringer Ingelheim Investigational Site
    • Virginia
      • Newport News, Virginia, Forenede Stater
        • 9.159.1077 Boehringer Ingelheim Investigational Site
      • Richmond, Virginia, Forenede Stater
        • 9.159.1021 Boehringer Ingelheim Investigational Site
      • Salem, Virginia, Forenede Stater
        • 9.159.1061 Boehringer Ingelheim Investigational Site
    • Washington
      • Seattle, Washington, Forenede Stater
        • 9.159.1014 Boehringer Ingelheim Investigational Site
      • Spokane, Washington, Forenede Stater
        • 9.159.1145 Boehringer Ingelheim Investigational Site
    • West Virginia
      • Charleston, West Virginia, Forenede Stater
        • 9.159.1211 Boehringer Ingelheim Investigational Site
      • Morgantown, West Virginia, Forenede Stater
        • 9.159.1035 Boehringer Ingelheim Investigational Site
    • Wisconsin
      • Marshfield, Wisconsin, Forenede Stater
        • 9.159.1030 Boehringer Ingelheim Investigational Site
      • Milwaukee, Wisconsin, Forenede Stater
        • 9.159.1117 Boehringer Ingelheim Investigational Site
      • Wausau, Wisconsin, Forenede Stater
        • 9.159.1098 Community Healthcare Clinic Westhill Medical Specialists
  • Frankrig
      • Lille cedex, Frankrig
        • 9.159.1680 Boehringer Ingelheim Investigational Site
      • Limoges cedex 1, Frankrig
        • 9.159.1683 Boehringer Ingelheim Investigational Site
      • Marseille cedex 05, Frankrig
        • 9.159.1681 Boehringer Ingelheim Investigational Site
      • Nancy, Frankrig
        • 9.159.1679 Boehringer Ingelheim Investigational Site
      • Paris cedex 19, Frankrig
        • 9.159.1685 Boehringer Ingelheim Investigational Site
      • Poitiers cedex, Frankrig
        • 9.159.1682 Boehringer Ingelheim Investigational Site
      • Tours cedex 9, Frankrig
        • 9.159.1684 Boehringer Ingelheim Investigational Site
  • Grækenland
      • Alexandroupolis, Grækenland
        • 9.159.1826 Boehringer Ingelheim Investigational Site
      • Athens, Grækenland
        • 9.159.1819 Boehringer Ingelheim Investigational Site
      • Athens, Grækenland
        • 9.159.1820 Boehringer Ingelheim Investigational Site
      • Athens, Grækenland
        • 9.159.1821 Boehringer Ingelheim Investigational Site
      • Ioannina, Grækenland
        • 9.159.1825 Boehringer Ingelheim Investigational Site
      • Patras, Grækenland
        • 9.159.1824 Boehringer Ingelheim Investigational Site
  • Holland
      • 's-Hertogenbosch, Holland
        • 9.159.1960 Jeroen Bosch Ziekenhuis
      • Alkmaar, Holland
        • 9.159.1945 Medisch Centrum Alkmaar
      • Assen, Holland
        • 9.159.1963 Polikliniek Neurologie
      • Blaricum, Holland
        • 9.159.1949 Ziekenhuis Gooi-Noord
      • Breda, Holland
        • 9.159.1962 Locatie Molengracht
      • Den Haag, Holland
        • 9.159.1950 HagaZiekenhuis
      • Eindhoven, Holland
        • 9.159.1959 Catharina Ziekenhuis
      • Emmen, Holland
        • 9.159.1946 Scheper Ziekenhuis
      • Enschede, Holland
        • 9.159.1958 Medisch Spectrum Twente
      • Groningen, Holland
        • 9.159.1943 Umcg
      • Groningen, Holland
        • 9.159.1961 Lokatie Van Swieten
      • Heerlen, Holland
        • 9.159.1953 Atrium Medisch Centrum
      • Helmond, Holland
        • 9.159.1955 Elkerliek Ziekenhuis
      • Hengelo, Holland
        • 9.159.1951 Ziekenhuisgroep Twente
      • Leeuwarden, Holland
        • 9.159.1948 Medisch Centrum Leeuwarden
      • Leiderdorp, Holland
        • 9.159.1952 Rijnland Ziekenhuis
      • Nieuwegein, Holland
        • 9.159.1947 Sint Antonius Ziekenhuis
      • Nijmegen, Holland
        • 9.159.1964 Canisius-Wilhelmina ziekenhuis
      • Tilburg, Holland
        • 9.159.1956 TweeSteden Ziekenhuis Tilburg
      • Tilburg, Holland
        • 9.159.1957 Sint Elisabeth Ziekenhuis
      • Veldhoven, Holland
        • 9.159.1944 Máxima Medisch Centrum
      • Weert, Holland
        • 9.159.1954 St. Jans Gasthuis
  • Hong Kong
      • Hong KoNG, Hong Kong
        • 9.159.2713 Boehringer Ingelheim Investigational Site
      • Hong Kong, Hong Kong
        • 9.159.2714 Boehringer Ingelheim Investigational Site
  • Indien
      • Annamalainagar, Indien
        • 9.159.2605 Boehringer Ingelheim Investigational Site
      • Bangalore, Indien
        • 9.159.2603 Boehringer Ingelheim Investigational Site
      • Bangalore, Indien
        • 9.159.2620 Boehringer Ingelheim Investigational Site
      • Bikaner, Indien
        • 9.159.2616 Boehringer Ingelheim Investigational Site
      • Calicut, Indien
        • 9.159.2618 Boehringer Ingelheim Investigational Site
      • Chennai, Indien
        • 9.159.2604 Boehringer Ingelheim Investigational Site
      • Chennai, Indien
        • 9.159.2619 Boehringer Ingelheim Investigational Site
      • Chennai, Indien
        • 9.159.2625 Boehringer Ingelheim Investigational Site
      • Cochin, Indien
        • 9.159.2606 Boehringer Ingelheim Investigational Site
      • Hyderabad, Indien
        • 9.159.2607 Boehringer Ingelheim Investigational Site
      • Hyderabad, Indien
        • 9.159.2624 Boehringer Ingelheim Investigational Site
      • Hyderabad, Indien
        • 9.159.2630 Boehringer Ingelheim Investigational Site
      • Hyderabad, Indien
        • 9.159.2632 Boehringer Ingelheim Investigational Site
      • Indore, Indien
        • 9.159.2610 Boehringer Ingelheim Investigational Site
      • Jaipur, Indien
        • 9.159.2615 Boehringer Ingelheim Investigational Site
      • Jaipur, Indien
        • 9.159.2617 Boehringer Ingelheim Investigational Site
      • Jodhpur, Indien
        • 9.159.2612 Boehringer Ingelheim Investigational Site
      • Kottayam, Indien
        • 9.159.2621 Boehringer Ingelheim Investigational Site
      • Lucknow, Indien
        • 9.159.2613 Boehringer Ingelheim Investigational Site
      • Ludhiana, Indien
        • 9.159.2614 Boehringer Ingelheim Investigational Site
      • Mumbai, Indien
        • 9.159.2611 Boehringer Ingelheim Investigational Site
      • New Delhi, Indien
        • 9.159.2628 Boehringer Ingelheim Investigational Site
      • New Delhi, Indien
        • 9.159.2629 Boehringer Ingelheim Investigational Site
      • Patiala, Indien
        • 9.159.2623 Boehringer Ingelheim Investigational Site
      • Pune, Indien
        • 9.159.2609 Boehringer Ingelheim Investigational Site
      • Pune, Indien
        • 9.159.2622 Boehringer Ingelheim Investigational Site
      • Secunderabad, Indien
        • 9.159.2627 Boehringer Ingelheim Investigational Site
      • Trichy, Indien
        • 9.159.2626 Boehringer Ingelheim Investigational Site
      • Visakhapatnam, Indien
        • 9.159.2631 Boehringer Ingelheim Investigational Site
      • Wardha, Indien
        • 9.159.2608 Boehringer Ingelheim Investigational Site
  • Irland
      • Cork, Irland
        • 9.159.1851 Boehringer Ingelheim Investigational Site
      • Dublin 7, Irland
        • 9.159.1852 Boehringer Ingelheim Investigational Site
  • Israel
      • Ashkelon, Israel
        • 9.159.2729 Barzilai Medical Center
      • Haifa, Israel
        • 9.159.2721 Neurology Unit
      • Haifa, Israel
        • 9.159.2724 Rambam Medical Center, Tel-Aviv Medical
      • Israel, Israel
        • 9.159.2723 Boehringer Ingelheim Investigational Site
      • Naharia, Israel
        • 9.159.2727 Western Galilee Hospital
      • Petach Tikva, Israel
        • 9.159.2722 Neurology Unit
      • Tel Hashomer, Israel
        • 9.159.2726 Sheba Medical Center
      • Tel-Aviv, Israel
        • 9.159.2725 Tel Aviv Medical Center
  • Italien
      • Ancona, Italien
        • 9.159.1875 Università degli Studi di Ancona
      • Cagliari, Italien
        • 9.159.1882 Ospedale Brotzu
      • Como, Italien
        • 9.159.1883 Azienda Ospedaliera S. Anna
      • Firenze, Italien
        • 9.159.1871 Azienda Ospedaliera "Careggi"
      • Genova, Italien
        • 9.159.1869 Università degli Studi di Genova
      • Jesi (ancona), Italien
        • 9.159.1870 ASL No. 5 di Jesi
      • L'aquila, Italien
        • 9.159.1865 Ospedale Regionale "S. Salvatore"
      • Milano, Italien
        • 9.159.1866 Ospedale S. Raffaele
      • Milano, Italien
        • 9.159.1873 Istituto Scientifico "S. Luca"
      • Milano, Italien
        • 9.159.1884 Ospedale S. Carlo Borromeo"
      • Napoli, Italien
        • 9.159.1868 Ospedale "S. Maria di Loreto Mare"
      • Padova, Italien
        • 9.159.1876 Azienda Ospedaliera di Padova -Policlinico Universitario
      • Palermo, Italien
        • 9.159.1874 Ospedale Civico - ARNAS
      • Pozzilli (IS), Italien
        • 9.159.1872 Neuromed IRCCS
      • Roma, Italien
        • 9.159.1879 Policlinico S. Andrea
      • Roma, Italien
        • 9.159.1881 Università "La Sapienza"
      • Siracusa, Italien
        • 9.159.1877 Azienda Ospedaliera Umberto I
      • Terni, Italien
        • 9.159.1878 Azienda Ospedaliera "Santo Maria"
      • Torino, Italien
        • 9.159.1864 Azienda Ospedaliera "S. Giovanni Battista"
      • Trieste, Italien
        • 9.159.1863 Ospedale di Cattinara
      • Vibo Valentia, Italien
        • 9.159.1867 Presidio Ospedaliero G.Jazzolino
      • Vicenza, Italien
        • 9.159.1880 Ospedale Civile
  • Japan
      • Adachi-ku, Tokyo, Japan
        • 9.159.2964 Boehringer Ingelheim Investigational Site
      • Akashi, Hyogo, Japan
        • 9.159.2958 Boehringer Ingelheim Investigational Site
      • Akashi, Hyogo, Japan
        • 9.159.2970 Boehringer Ingelheim Investigational Site
      • Ako, Hyogo, Japan
        • 9.159.2965 Boehringer Ingelheim Investigational Site
      • Aoba-ku, Yokohama, Kanagawa, Japan
        • 9.159.2968 Boehringer Ingelheim Investigational Site
      • Azumino, Nagano, Japan
        • 9.159.2951 Boehringer Ingelheim Investigational Site
      • Chitose, Hokkaido, Japan
        • 9.159.2959 Boehringer Ingelheim Investigational Site
      • Chuo-Ku, Sapporo, Hokkaido, Japan
        • 9.159.2947 Boehringer Ingelheim Investigational Site
      • Chuo-ku, Kobe, Hyogo, Japan
        • 9.159.2944 Boehringer Ingelheim Investigational Site
      • Fushimi-ku, Kyoto, Kyoto, Japan
        • 9.159.2954 Boehringer Ingelheim Investigational Site
      • Habikino, Osaka, Japan
        • 9.159.2942 Boehringer Ingelheim Investigational Site
      • Higashi-ku, Sapporo, Hokkaido, Japan
        • 9.159.2948 Boehringer Ingelheim Investigational Site
      • Higashi-osaka, Osaka, Japan
        • 9.159.2957 Boehringer Ingelheim Investigational Site
      • Higashinari-ku, Osaka, Osaka, Japan
        • 9.159.2940 Boehringer Ingelheim Investigational Site
      • Higashiyodogawa-ku, Osaka, Osaka, Japan
        • 9.159.2973 Boehringer Ingelheim Investigational Site
      • Hitachinaka, Ibaraki, Japan
        • 9.159.2949 Boehringer Ingelheim Investigational Site
      • Iida, Nagano, Japan
        • 9.159.2953 Boehringer Ingelheim Investigational Site
      • Izumisano, Osaka, Japan
        • 9.159.2943 Boehringer Ingelheim Investigational Site
      • Jyonan-ku, Fukuoka, Fukuoka, Japan
        • 9.159.2963 Boehringer Ingelheim Investigational Site
      • Kasama, Ibaraki, Japan
        • 9.159.2933 Boehringer Ingelheim Investigational Site
      • Kasuga, Fukuoka, Japan
        • 9.159.2955 Boehringer Ingelheim Investigational Site
      • Kita-ku, Osaka, Osaka, Japan
        • 9.159.2938 Boehringer Ingelheim Investigational Site
      • Koriyama, Fukushima, Japan
        • 9.159.2967 Boehringer Ingelheim Investigational Site
      • Kushiro, Hokkaido, Japan
        • 9.159.2969 Boehringer Ingelheim Investigational Site
      • Matsumoto, Nagano, Japan
        • 9.159.2952 Boehringer Ingelheim Investigational Site
      • Midori-ku, Yokohama, Kanagawa, Japan
        • 9.159.2961 Boehringer Ingelheim Investigational Site
      • Moriya, Ibaraki, Japan
        • 9.159.2934 Boehringer Ingelheim Investigational Site
      • Musashino, Tokyo, Japan
        • 9.159.2971 Boehringer Ingelheim Investigational Site
      • Nakagawa-ku, Nagoya, Aichi, Japan
        • 9.159.2962 Boehringer Ingelheim Investigational Site
      • Nishi-yodogawa-ku, Osaka, Osaka, Japan
        • 9.159.2939 Boehringer Ingelheim Investigational Site
      • Ohnojo, Fukuoka, Japan
        • 9.159.2956 Boehringer Ingelheim Investigational Site
      • Sakai-ku, Sakai, Osaka, Japan
        • 9.159.2941 Boehringer Ingelheim Investigational Site
      • Sawara-ku, Fukuoka, Fukuoka, Japan
        • 9.159.2945 Boehringer Ingelheim Investigational Site
      • Shimogyo-ku, Kyoto, Kyoto, Japan
        • 9.159.2937 Boehringer Ingelheim Investigational Site
      • Shiroishi, Miyagi, Japan
        • 9.159.2966 Boehringer Ingelheim Investigational Site
      • Suwa, Nagano, Japan
        • 9.159.2936 Boehringer Ingelheim Investigational Site
      • Takikawa, Hokkaido, Japan
        • 9.159.2946 Boehringer Ingelheim Investigational Site
      • Tatebayashi, Gunma, Japan
        • 9.159.2935 Boehringer Ingelheim Investigational Site
      • Tsuchiura, Ibaraki, Japan
        • 9.159.2950 Boehringer Ingelheim Investigational Site
      • Yao, Osaka, Japan
        • 9.159.2972 Boehringer Ingelheim Investigational Site
  • Kalkun
      • Ankara, Kalkun
        • 9.159.2830 Boehringer Ingelheim Investigational Site
      • Antalya, Kalkun
        • 9.159.2829 Boehringer Ingelheim Investigational Site
      • Bursa, Kalkun
        • 9.159.2831 Boehringer Ingelheim Investigational Site
      • Eskisehir, Kalkun
        • 9.159.2827 Boehringer Ingelheim Investigational Site
      • Istanbul, Kalkun
        • 9.159.2825 Boehringer Ingelheim Investigational Site
      • Istanbul, Kalkun
        • 9.159.2826 Boehringer Ingelheim Investigational Site
      • Izmir, Kalkun
        • 9.159.2828 Dkuz Eylul Universitesi Tip Fakultesi Noroloji A.B.D.
  • Kina
      • Beijing, Kina
        • 9.159.2490 Boehringer Ingelheim Investigational Site
      • Beijing, Kina
        • 9.159.2491 Boehringer Ingelheim Investigational Site
      • Beijing, Kina
        • 9.159.2492 Boehringer Ingelheim Investigational Site
      • Beijing, Kina
        • 9.159.2493 Boehringer Ingelheim Investigational Site
      • Beijing, Kina
        • 9.159.2494 Boehringer Ingelheim Investigational Site
      • Beijing, Kina
        • 9.159.2495 Boehringer Ingelheim Investigational Site
      • Beijing, Kina
        • 9.159.2496 Boehringer Ingelheim Investigational Site
      • Changchun, Jilin Province, Kina
        • 9.159.2503 Boehringer Ingelheim Investigational Site
      • Changsha, Hunan Province, Kina
        • 9.159.2500 Boehringer Ingelheim Investigational Site
      • Chengdu, Sichuan Province, Kina
        • 9.159.2513 Boehringer Ingelheim Investigational Site
      • Chongqing, Kina
        • 9.159.2512 Boehringer Ingelheim Investigational Site
      • Guangzhou, Kina
        • 9.159.2509 Boehringer Ingelheim Investigational Site
      • Guangzhou, Kina
        • 9.159.2518 Boehringer Ingelheim Investigational Site
      • Guangzhou, Kina
        • 9.159.2521 Boehringer Ingelheim Investigational Site
      • Guangzhou, Guangdong Province, Kina
        • 9.159.2507 Boehringer Ingelheim Investigational Site
      • Guangzhou, Guangdong Province, Kina
        • 9.159.2510 Boehringer Ingelheim Investigational Site
      • Hangzhou, Zhejiang Province, Kina
        • 9.159.2502 Boehringer Ingelheim Investigational Site
      • Harbin, Heilongjiang Province, Kina
        • 9.159.2504 Boehringer Ingelheim Investigational Site
      • Jinan, Shandong Province, Kina
        • 9.159.2505 Boehringer Ingelheim Investigational Site
      • Jinan, Shangdong Province, Kina
        • 9.159.2506 Boehringer Ingelheim Investigational Site
      • Nanjing, Jiangsu Province, Kina
        • 9.159.2517 Boehringer Ingelheim Investigational Site
      • Nanjing, Jiangsu Province, Kina
        • 9.159.2519 Boehringer Ingelheim Investigational Site
      • Nanjing, Jiangsu Province, Kina
        • 9.159.2520 Boehringer Ingelheim Investigational Site
      • Shanghai, Kina
        • 9.159.2483 Boehringer Ingelheim Investigational Site
      • Shanghai, Kina
        • 9.159.2484 Boehringer Ingelheim Investigational Site
      • Shanghai, Kina
        • 9.159.2485 Boehringer Ingelheim Investigational Site
      • Shanghai, Kina
        • 9.159.2486 Boehringer Ingelheim Investigational Site
      • Shanghai, Kina
        • 9.159.2487 Boehringer Ingelheim Investigational Site
      • Shanghai, Kina
        • 9.159.2488 Boehringer Ingelheim Investigational Site
      • Shanghai, Kina
        • 9.159.2489 Boehringer Ingelheim Investigational Site
      • Suzhou, Jiangsu Province, Kina
        • 9.159.2516 Boehringer Ingelheim Investigational Site
      • Tianjin, Kina
        • 9.159.2497 Boehringer Ingelheim Investigational Site
      • Wenzhou, Zhejiang Province, Kina
        • 9.159.2501 Boehringer Ingelheim Investigational Site
      • Wuhan, Hubei Province, Kina
        • 9.159.2498 Boehringer Ingelheim Investigational Site
      • Wuhan, Hubei Province, Kina
        • 9.159.2499 Boehringer Ingelheim Investigational Site
      • Xian, Kina
        • 9.159.2511 Boehringer Ingelheim Investigational Site
      • Xian, Shanxi, Kina
        • 9.159.2514 Boehringer Ingelheim Investigational Site
      • Xian, Shanxi Province, Kina
        • 9.159.2515 Boehringer Ingelheim Investigational Site
  • Korea, Republikken
      • Gwangju, Korea, Republikken
        • 9.159.1593 Boehringer Ingelheim Investigational Site
      • Incheon, Korea, Republikken
        • 9.159.1595 Boehringer Ingelheim Investigational Site
      • Kyunggi-do, Korea, Republikken
        • 9.159.1592 Boehringer Ingelheim Investigational Site
      • Seoul, Korea, Republikken
        • 9.159.1591 Boehringer Ingelheim Investigational Site
      • Seoul, Korea, Republikken
        • 9.159.1594 Boehringer Ingelheim Investigational Site
      • Seoul, Korea, Republikken
        • 9.159.1597 Boehringer Ingelheim Investigational Site
      • Suwon, Korea, Republikken
        • 9.159.1596 Boehringer Ingelheim Investigational Site
  • Malaysia
      • Kelantan Darul Naim, Malaysia
        • 9.159.2707 Boehringer Ingelheim Investigational Site
      • Kuala Lumpur, Malaysia
        • 9.159.2706 Boehringer Ingelheim Investigational Site
  • Mexico
      • Metepec, Mexico
        • 9.159.2765 Boehringer Ingelheim Investigational Site
  • Norge
      • Bergen, Norge
        • 9.159.2029 Boehringer Ingelheim Investigational Site
      • Oslo, Norge
        • 9.159.2028 Boehringer Ingelheim Investigational Site
      • Trondheim, Norge
        • 9.159.2027 Boehringer Ingelheim Investigational Site
  • Portugal
      • Amadora, Portugal
        • 9.159.2040 Hospital Fernando Fonseca
      • Coimbra, Portugal
        • 9.159.2039 Centro Hospitalar e Universitário de Coimbra, EPE
      • Lisboa, Portugal
        • 9.159.2041 Centro Hospitalar de Lisboa Norte
      • Porto, Portugal
        • 9.159.2042 Centro Hospitalar do Porto
  • Singapore
      • Singapore, Singapore
        • 9.159.2703 Boehringer Ingelheim Investigational Site
      • Singapore, Singapore
        • 9.159.2704 Boehringer Ingelheim Investigational Site
      • Singapore, Singapore
        • 9.159.2705 Boehringer Ingelheim Investigational Site
  • Spanien
      • Alicante, Spanien
        • 9.159.2179 Boehringer Ingelheim Investigational Site
      • Barcelona, Spanien
        • 9.159.2177 Boehringer Ingelheim Investigational Site
      • Hospitalet de Llobregat (Barcelona), Spanien
        • 9.159.2178 Boehringer Ingelheim Investigational Site
      • Madrid, Spanien
        • 9.159.2175 Boehringer Ingelheim Investigational Site
      • Madrid, Spanien
        • 9.159.2176 Boehringer Ingelheim Investigational Site
      • Pamplona, Spanien
        • 9.159.2180 Boehringer Ingelheim Investigational Site
  • Sverige
      • Borås, Sverige
        • 9.159.2223 Boehringer Ingelheim Investigational Site
      • Eskilstuna, Sverige
        • 9.159.2209 Boehringer Ingelheim Investigational Site
      • Göteborg, Sverige
        • 9.159.2204 Boehringer Ingelheim Investigational Site
      • Göteborg, Sverige
        • 9.159.2205 Boehringer Ingelheim Investigational Site
      • Holon, Sverige
        • 9.159.2728 Neurology Unit
      • Jönköping, Sverige
        • 9.159.2210 Boehringer Ingelheim Investigational Site
      • Lund, Sverige
        • 9.159.2206 Boehringer Ingelheim Investigational Site
      • Mora, Sverige
        • 9.159.2211 Boehringer Ingelheim Investigational Site
      • Skellefteå, Sverige
        • 9.159.2216 Boehringer Ingelheim Investigational Site
      • Skövde, Sverige
        • 9.159.2215 Boehringer Ingelheim Investigational Site
      • Stockholm, Sverige
        • 9.159.2203 Boehringer Ingelheim Investigational Site
      • Stockholm, Sverige
        • 9.159.2212 Boehringer Ingelheim Investigational Site
      • Stockholm, Sverige
        • 9.159.2213 Boehringer Ingelheim Investigational Site
      • Stockholm, Sverige
        • 9.159.2222 Boehringer Ingelheim Investigational Site
      • Stockholm, Sverige
        • 9.159.2225 Boehringer Ingelheim Investigational Site
      • Umeå, Sverige
        • 9.159.2207 Boehringer Ingelheim Investigational Site
      • Värnamo, Sverige
        • 9.159.2214 Boehringer Ingelheim Investigational Site
      • Västervik, Sverige
        • 9.159.2224 Boehringer Ingelheim Investigational Site
      • Örebro, Sverige
        • 9.159.2208 Boehringer Ingelheim Investigational Site
  • Sydafrika
      • Bloemfontein, Sydafrika
        • 9.159.2060 Boehringer Ingelheim Investigational Site
      • Cape Town, Sydafrika
        • 9.159.2056 Boehringer Ingelheim Investigational Site
      • Durban, Sydafrika
        • 9.159.2057 Boehringer Ingelheim Investigational Site
      • Johannesburg, Sydafrika
        • 9.159.2055 Boehringer Ingelheim Investigational Site
      • Johannesburg, Sydafrika
        • 9.159.2061 Boehringer Ingelheim Investigational Site
      • Pretoria, Sydafrika
        • 9.159.2058 Boehringer Ingelheim Investigational Site
      • Sunninghill, Sydafrika
        • 9.159.2059 Boehringer Ingelheim Investigational Site
  • Taiwan
      • Kaohsiung, Taiwan
        • 9.159.2250 Boehringer Ingelheim Investigational Site
      • Kaohsiung, Taiwan
        • 9.159.2253 Boehringer Ingelheim Investigational Site
      • Taichung, Taiwan
        • 9.159.2248 Boehringer Ingelheim Investigational Site
      • Taichung, Taiwan
        • 9.159.2249 Boehringer Ingelheim Investigational Site
      • Tainan, Taiwan
        • 9.159.2251 Boehringer Ingelheim Investigational Site
      • Taipei, Taiwan
        • 9.159.2244 Boehringer Ingelheim Investigational Site
      • Taipei, Taiwan
        • 9.159.2245 Boehringer Ingelheim Investigational Site
      • Taipei, Taiwan
        • 9.159.2246 Boehringer Ingelheim Investigational Site
      • Taipei, Taiwan
        • 9.159.2247 Boehringer Ingelheim Investigational Site
      • Taipei, Taiwan
        • 9.159.2252 Boehringer Ingelheim Investigational Site
      • Taipei, Taiwan
        • 9.159.2254 Boehringer Ingelheim Investigational Site
      • Taoyuan, Taiwan
        • 9.159.2243 Boehringer Ingelheim Investigational Site
  • Thailand
      • Bangkok, Thailand
        • 9.159.2797 Boehringer Ingelheim Investigational Site
      • Bangkok, Thailand
        • 9.159.2798 Boehringer Ingelheim Investigational Site
      • Bangkok, Thailand
        • 9.159.2799 Boehringer Ingelheim Investigational Site
      • Bangkok, Thailand
        • 9.159.2800 Boehringer Ingelheim Investigational Site
      • Chiang Mai, Thailand
        • 9.159.2801 Boehringer Ingelheim Investigational Site
  • Tyskland
      • Bad Neustadt/Saale, Tyskland
        • 9.159.1713 Boehringer Ingelheim Investigational Site
      • Berlin, Tyskland
        • 9.159.1736 Boehringer Ingelheim Investigational Site
      • Braunschweig, Tyskland
        • 9.159.1732 Boehringer Ingelheim Investigational Site
      • Cloppenburg, Tyskland
        • 9.159.1726 Boehringer Ingelheim Investigational Site
      • Dresden, Tyskland
        • 9.159.1723 Boehringer Ingelheim Investigational Site
      • Düsseldorf, Tyskland
        • 9.159.1728 Boehringer Ingelheim Investigational Site
      • Essen, Tyskland
        • 9.159.1707 Boehringer Ingelheim Investigational Site
      • Freiburg, Tyskland
        • 9.159.1738 Boehringer Ingelheim Investigational Site
      • Gießen, Tyskland
        • 9.159.1720 Boehringer Ingelheim Investigational Site
      • Hamburg, Tyskland
        • 9.159.1722 Boehringer Ingelheim Investigational Site
      • Hamburg, Tyskland
        • 9.159.1739 Boehringer Ingelheim Investigational Site
      • Heidelberg, Tyskland
        • 9.159.1724 Boehringer Ingelheim Investigational Site
      • Jena, Tyskland
        • 9.159.1734 Boehringer Ingelheim Investigational Site
      • Kaiserslautern, Tyskland
        • 9.159.1730 Boehringer Ingelheim Investigational Site
      • Köln, Tyskland
        • 9.159.1737 Boehringer Ingelheim Investigational Site
      • Leipzig, Tyskland
        • 9.159.1717 Boehringer Ingelheim Investigational Site
      • Ludwigshafen am Rhein, Tyskland
        • 9.159.1735 Boehringer Ingelheim Investigational Site
      • Magdeburg, Tyskland
        • 9.159.1712 Boehringer Ingelheim Investigational Site
      • Mainz, Tyskland
        • 9.159.1710 Boehringer Ingelheim Investigational Site
      • Minden, Tyskland
        • 9.159.1709 Boehringer Ingelheim Investigational Site
      • Mönchengladbach, Tyskland
        • 9.159.1716 Boehringer Ingelheim Investigational Site
      • München, Tyskland
        • 9.159.1718 Boehringer Ingelheim Investigational Site
      • München, Tyskland
        • 9.159.1725 Boehringer Ingelheim Investigational Site
      • München, Tyskland
        • 9.159.1729 Boehringer Ingelheim Investigational Site
      • Münster, Tyskland
        • 9.159.1727 Boehringer Ingelheim Investigational Site
      • Nürnberg, Tyskland
        • 9.159.1711 Boehringer Ingelheim Investigational Site
      • Regensburg, Tyskland
        • 9.159.1719 Boehringer Ingelheim Investigational Site
      • Remscheid, Tyskland
        • 9.159.1731 Boehringer Ingelheim Investigational Site
      • Rostock, Tyskland
        • 9.159.1708 Boehringer Ingelheim Investigational Site
      • Saarbrücken, Tyskland
        • 9.159.1715 Boehringer Ingelheim Investigational Site
      • Siegen, Tyskland
        • 9.159.1714 Boehringer Ingelheim Investigational Site
      • Stuttgart, Tyskland
        • 9.159.1733 Boehringer Ingelheim Investigational Site
      • Weimar, Tyskland
        • 9.159.1721 Boehringer Ingelheim Investigational Site
  • Ukraine
      • Dnepropetrovsk, Ukraine
        • 9.159.2387 Boehringer Ingelheim Investigational Site
      • Kharkiv, Ukraine
        • 9.159.2384 Boehringer Ingelheim Investigational Site
      • Kharkiv, Ukraine
        • 9.159.2385 Boehringer Ingelheim Investigational Site
      • Kharkiv, Ukraine
        • 9.159.2386 Boehringer Ingelheim Investigational Site
      • Kharkiv, Ukraine
        • 9.159.2392 Boehringer Ingelheim Investigational Site
      • Kyiv, Ukraine
        • 9.159.2379 Boehringer Ingelheim Investigational Site
      • Kyiv, Ukraine
        • 9.159.2380 Boehringer Ingelheim Investigational Site
      • Kyiv, Ukraine
        • 9.159.2382 Boehringer Ingelheim Investigational Site
      • Odesa, Ukraine
        • 9.159.2389 Boehringer Ingelheim Investigational Site
      • Odesa, Ukraine
        • 9.159.2390 Boehringer Ingelheim Investigational Site
      • Vinnytzya, Ukraine
        • 9.159.2391 Boehringer Ingelheim Investigational Site
      • Zaporizhzhya, Ukraine
        • 9.159.2388 Boehringer Ingelheim Investigational Site
  • Østrig
      • Graz, Østrig
        • 9.159.1515 Boehringer Ingelheim Investigational Site
      • Graz, Østrig
        • 9.159.1519 Boehringer Ingelheim Investigational Site
      • Innsbruck, Østrig
        • 9.159.1517 Boehringer Ingelheim Investigational Site
      • Linz, Østrig
        • 9.159.1516 Boehringer Ingelheim Investigational Site
      • Ma.Gugging/Klosterneuburg, Østrig
        • 9.159.1518 Boehringer Ingelheim Investigational Site
      • St. Pölten, Østrig
        • 9.159.1520 Boehringer Ingelheim Investigational Site
      • Wien, Østrig
        • 9.159.1521 Boehringer Ingelheim Investigational Site

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

50 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inklusionskriterier:

Mandlige eller kvindelige forsøgspersoner på 55 år eller ældre, som har haft et iskæmisk slagtilfælde inden for de seneste 90 dage, og som opfylder alle andre inklusionskriterier. Inkluder også patienter i alderen 50 - 54 år og/eller 90 til 120 dage efter det kvalificerende slagtilfælde, forudsat at patienten har mindst to af følgende yderligere risikofaktorer:

  • Diabetes mellitus
  • Hypertension (systolisk BP ¿ 140 eller diastolisk BP ¿ 90)
  • Ryger på tidspunktet for kvalificerende slagtilfælde
  • Fedme (BMI>30; BMI=vægt (kg)/[højde (m)]2)
  • Tidligere vaskulær sygdom (slagtilfælde, MI eller perifer arteriel sygdom før kvalificeret slagtilfælde)
  • End-organ-beskadigelse (retinopati, LVH eller mikroalbuminuri)
  • Hyperlipidæmi

Ekskluderingskriterier:

hæmoragisk slagtilfælde (skal udelukkes ved billeddannelse); ude af stand til at give informeret samtykke; kendt hjernetumor, alvorlig nyre- eller leverinsufficiens, aktuel aktiv mavesårsygdom, alvorlig koronararteriesygdom, herunder ustabil angina pectoris eller MI inden for de foregående 3 måneder, eller historie med en hæmostatisk lidelse eller systemisk blødning; hyperkaliæmi; ukorrigeret volumen eller natriumdepletion ; anamnese med demens før slagtilfælde;modificeret Rankin-score større end 4;kvalificerende slagtilfælde induceret ved kirurgisk eller kardiovaskulær procedure;ukontrolleret hypertension ved indtræden over 180/110 mmHg (mål-BP er lavere); SBP 120 mmHg eller mindre for indlagte patienter; tager i øjeblikket en ARB og er ikke i stand til eller villig til at skifte til alternativ; påkrævet eller planlagt fortsat behandling med antitrombotika eller antikoagulantia, herunder heparin eller warfarin eller ikke-studie trombocythæmmere; syndrom af astma, rhinitis og nasale polypper; planlagt til større operation, carotis endarterektomi eller carotis angioplastik (4 uger efter operation er tilladt); usandsynligt at blive udskrevet fra hospitalet efter det kvalificerende slagtilfælde eller tilstedeværelse af et alvorligt handicap, der sandsynligvis vil føre til sengeliggende eller dement eller en ikke-vaskulær sygdom eller tilstand, som gør det usandsynligt, at patienten vil overleve til slutningen af ​​forsøget; historie med trombocytopeni eller neutropeni.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Forebyggelse
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Dobbelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Placebo komparator: Aggrenox, Clopidogrel placebo, Micardis
Aggrenox (25mg/200mg) bid, clopidogrel placebo qd, Micardis (80mg) qd
Medicin: Aggrenox
25 mg aspirin, 200 mg dipyridamol
Medicin: Clopidogrel placebo
placebo
Medicin: Micardis
80 mg micardis
Placebo komparator: Aggrenox placebo, clopidogrel,, Micardis
Clopidogrel (75 mg) qd; Aggrenox placebo bud, Micardis (80 mg) qd
Medicin: Micardis
80 mg micardis
Medicin: Aggrenox placebo
placebo
Medicin: Clopidogrel
75 mg clopidogrel
Placebo komparator: Aggrenox, clop placebo, micardis placebo
Aggrenox (25mg/200mg) bid, clopidogrel placebo qd, Micardis placebo qd
Medicin: Aggrenox
25 mg aspirin, 200 mg dipyridamol
Medicin: Clopidogrel placebo
placebo
Medicin: Micardis placebo
placebo
Placebo komparator: Aggrenox plcebo, clop, micardis placebo
Clopidogrel (75 mg) qd, Aggrenox placebo bud, Micardis placebo qd.
Medicin: Aggrenox placebo
placebo
Medicin: Clopidogrel
75 mg clopidogrel
Medicin: Micardis placebo
placebo

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Tidsramme
Antal patienter med første tilbagevendende slagtilfælde af enhver type, dødelig eller ikke-dødelig (kun antiplatelet-sammenligning)
Tidsramme: tid siden randomisering; opfølgningsperioden er 1,5 til 4,4 år
tid siden randomisering; opfølgningsperioden er 1,5 til 4,4 år
Antal patienter med første tilbagevendende slagtilfælde af enhver type, dødelig eller ikke-dødelig (kun Telmisartan vs. Placebo)
Tidsramme: tid siden randomisering; opfølgningsperioden er 1,5 til 4,4 år
tid siden randomisering; opfølgningsperioden er 1,5 til 4,4 år

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Sammensat udfald af slagtilfælde, myokardieinfarkt (MI) eller vaskulær død (kun sammenligning med antiblodplader)
Tidsramme: tid siden randomisering; opfølgningsperioden er 1,5 til 4,4 år
Antal patienter med nogen af ​​slagtilfælde, myokardieinfarkt, vaskulær død
tid siden randomisering; opfølgningsperioden er 1,5 til 4,4 år
Sammensat resultat af slagtilfælde, myokardieinfarkt, vaskulær død eller ny eller forværret kongestiv hjertesvigt (CHF) (kun Telmisartan vs. Placebo)
Tidsramme: tid siden randomisering; opfølgningsperioden er 1,5 til 4,4 år
Antal patienter med slagtilfælde, myokardieinfarkt, vaskulær død eller ny eller forværret kongestiv hjertesvigt
tid siden randomisering; opfølgningsperioden er 1,5 til 4,4 år
Antal patienter med nystartet diabetes (kun Telmisartan vs. placebo)
Tidsramme: Randomisering til endelig patientkontakt
Randomisering til endelig patientkontakt

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Boehringer Ingelheim

Samarbejdspartnere

Bayer
GlaxoSmithKline

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Generelle publikationer

Hjælpsomme links

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart

1. august 2003

Primær færdiggørelse (Faktiske)

1. april 2008

Datoer for studieregistrering

Først indsendt

9. september 2005

Først indsendt, der opfyldte QC-kriterier

9. september 2005

Først opslået (Skøn)

12. september 2005

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Skøn)

13. maj 2014

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

22. april 2014

Sidst verificeret

1. april 2014

Mere information

Begreber relateret til denne undersøgelse

Yderligere relevante MeSH-vilkår

Andre undersøgelses-id-numre

  • 9.159

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med Aggrenox

Søg i lignende forsøg

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

CROs by country

CROs in Turkmenistan

Betingelser

Sjældne sygdomme

Narkotikainterventioner

Kosttilskud

Sponsor / samarbejdspartnere

Placeringer

3
Abonner